A case of hypoglycemia due to illegitimate sexual enhancement medication.
Sexual enhancement medication presents a large market for counterfeit versions. We report here a case of hypoglycemia caused by an illicit sexual enhancement medication containing an extremely large amount of the sulfonylurea drug glibenclamide together with a moderate amount sildenafil citrate.
Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, 2-1-7 Fukushima-ku, Osaka 553-0003, Japan.
Naoki
N
Kuramoto
Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, 2-1-7 Fukushima-ku, Osaka 553-0003, Japan; Center for Metabolism and Clinical Nutrition, Kansai Electric Power Hospital, 2-1-7 Fukushima-ku, Osaka 553-0003, Japan. Electronic address: ydaisuke-kyoto@umin.ac.jp.
Daisuke
D
Yabe
Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, 2-1-7 Fukushima-ku, Osaka 553-0003, Japan.
Takeshi
T
Kurose
Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, 2-1-7 Fukushima-ku, Osaka 553-0003, Japan.
Yutaka
Y
Seino
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D004338:Drug Combinations; D007172:Erectile Dysfunction / Q000188:drug therapy; D005905:Glyburide / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000139:chemically induced*; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D000068677:Sildenafil Citrate / Q000009:adverse effects* / Q000627:therapeutic use
D001786:Blood Glucose; D004338:Drug Combinations; D007004:Hypoglycemic Agents; D058986:Phosphodiesterase 5 Inhibitors; D000068677:Sildenafil Citrate; D005905:Glyburide
Glibenclamide; Hypoglycemia; Sexual enhancement medication; Sildenafil citrate